See other companies on Welcome to the Jungle
Legacy
Digital fertility clinic for men
- 101-200 employees
- Healthcare
- B2C
- Personal health
- Biology
- eCommerce
- Evanston Township, Evanston, IL
Jump to section
Company mission
To change the outdated view that fertility is a "women's issue" by creating an accessible, affordable product for males.
51% employee growth in 12 months
Our take
Reports suggest that one in six couples are unable to conceive after one year of trying, with a third of infertility cases in these couples caused by fertility problems in men. Based out of the Harvard Innovation Labs, Legacy is an at-home testing kit that aims to help men understand their fertility without having to visit a clinic.
In a similar fashion to systems like Ancestry and 23andMe, clients order a kit through the mail, with their sample collected and taken to a lab for analysis. The results are sent digitally, giving the client insight into data such as sperm count, volume, concentration, and motility.
The company is investing in expanding its optional analysis and cryogenic storage service add-ons. Legacy has rivals in the male fertility market such as Dadi and Trak, which offer similar services, while the startup Mate Fertility is opening modern fertility clinics around the country.
Steph
Company Specialist at Welcome to the Jungle
Benefits
- Other perks
- 401K
- Unlimited time off
- Unlimited 'Health & Wellness' stipend where we pay for 75% of anything you deem might improve your life (Mattresses, Pelotons, etc.)
- Health care
Company values
- Have bias towards action - This is your company, too. Work with your team, for the customer, and get sh*t done.
- Understand the customer - Know the intimate details. Remove friction when possible. And delight, even if it's expensive.
- Check in emotionally - Work is challenging, and your mental and emotional health is important. Be a part of a team that will ask how you feel often.
- There's always a reason to clap - Celebration is at our core. We believe winning is important, and should be recognised. We clap with wild abandon, get ready.
- Have humility for you and the company - Diversity is important, as an organisation and for an individual. We welcome all kinds of it.
Funding (last 2 of 7 rounds)
Jul 2024
$7.5m
LATE VC
May 2022
$25m
SERIES B
Total funding: $87.5m
This company has top investors
Leadership
Khaled Kteily
(CEO)Former Senior Consultant in Healthcare and Life Sciences at Oliver Wyman and then Senior Manager and Global Leadership Fellow at the World Economic Forum.